Navigation Links
Microbix Announces A New Technology Platform For The SST Project
Date:4/7/2009

    New intellectual property strengthens shareholders' exclusive access to
    the global livestock AI industry

TORONTO, April 7 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) announced today that the Company is proceeding to submit a new patent application, based on discoveries arising from its extensive work on the Semen Sexing Technology (SST) program.

The new technology represents a significant departure from other methods to separate sperm cells by sex, and will potentially provide the Company with a further entree into the global Artificial Insemination (AI) industry. The technology affords shareholders a strong and exclusive intellectual property position and a simplified path through development and commercialization. The Company does not anticipate significant further research-phase investment in SST, and anticipates the ability to focus exclusively on development and commercialization activities with timelines determined accordingly.

"In the high risk world of biotech R&D, this is a success by any standard," said Microbix Chief Executive Officer William J. Gastle. "New intellectual property, in a large market, with a significant competitive advantage, are all criteria to be met when creating shareholder value. That is what we have done here."

The worldwide AI market is over $ 2.5 billion and Microbix estimates that sexed semen will garner a premium price of about 2.5 times the price of unsexed semen product. The Company's previous estimate of royalties of 15% of sales remains unchanged with the new technology. A number of AI companies representing 13% of the market have already agreed to participate in field trials.

The acquisition of the initial protein-based technology and assets from Sequent Biotechnologies in 2005 gave Microbix a significant lead in understanding the structural differences between X and Y chromosome-bearing bovine sperm. In June 2007 the Company reported
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
4. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
5. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
6. Immunotech Laboratories Announces South American Strategy
7. Siemens Healthcare Announces Planned Collaboration with Harris Corporation
8. ChromaDex Announces 2008 Year End Financial Results
9. China Agri-Business Announces 2008 Operating Results
10. Verenium Announces Organizational Changes
11. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Follow us on LinkedIn ... has groomed and nurtured anti-aging products and technologies ... on appearance maintenance is benefitting the market for ... obtained from the bacterium, Clostridium Botulinum, which arrests ... With cosmetic indications for botulinum toxin ranging from ...
(Date:9/22/2014)... (Nasdaq: NEOG ) announced today that net ... year, which ended Aug. 31, was $8,883,000 — a ... the first quarter of last year. Adjusted for a ... share in the current quarter were $0.24, compared to ... increased 15% to $67,599,000, from the previous year,s first ...
(Date:9/22/2014)... Olso, Norway (PRWEB) September 22, 2014 ... convenient new parcel and pallet measuring device ... ScanTape™ eliminates manual data entry, offering greater ease ... time savings that result can significantly enhance productivity—an ... in industries where processing volume equals profits. ...
(Date:9/21/2014)... For the first time, scientists have discovered how to ... strength and stiffness greater than that of today,s strongest ... a research team led by John V. Badding, a ... published in the 21 September 2014 issue of the ... point of view, our discovery is intriguing because the ...
Breaking Biology Technology:Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7ScanTape™ Handheld Dimensioner Increases Processing Volume 2Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4
... Inc.,(Nasdaq: VTIV ) today announced that Eran ... Officer, will make a presentation at the,2008 UBS ... which will,be held February 11-13, 2008. The conference ... management presentations and,extensive Q&A opportunities., inVentiv,s presentation ...
... Services to Unprecedented Number of ... Elderly and Bariatric Patients, MALVERN, Pa., Feb. 4 ... the first facility in the United,States to install the ... (http://www.usa.siemens.com/healthcare ) -- the,MAGNETOM(R) Verio. Combining 3 Tesla ...
... Chantix and Cialis Lead, Many Heavily Advertised Brands ... Manhattan Research, a leader in,syndicated research and marketing ... the top pharmaceutical branded,product websites ranked by offline ... are based on the comprehensive online consumer,research study ...
Cached Biology Technology:inVentiv Health to Present at the 2008 UBS Global Healthcare Services Conference 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 3Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates 2
(Date:9/21/2014)... Stanford researchers has developed a protein therapy that disrupts ... from original tumor sites, travel through the blood stream ... , This process, known as metastasis, can cause cancer ... of patients who succumb to cancer fall prey to ... associate professor of bioengineering who describes a new therapeutic ...
(Date:9/19/2014)... resource unveiled today by researchers from several Harvard ... provides both experienced and aspiring researchers with the ... operate robots made from soft, flexible materials. , ... cutters, and other advances in manufacturing technology, soft ... Using principles drawn from conventional rigid robot design, ...
(Date:9/19/2014)... A University of Oklahoma biology professor will study ... control leg movements with a National Science Foundation ... four-year project. , Ari Berkowitz, professor in the ... Sciences, will focus on the differences between the ... understand what neurotransmitters they use and what connections ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Soft robotics 'toolkit' features everything a robot-maker needs 2
... of a human brain and squeeze it into a special chamber ... chamber filled with cerebral spinal fluid and thread both of them ... makes the neurons and other brain cells behave as if they ... battery of sensors that monitor how the cells respond when exposed ...
... special issue of ZooKeys , initiated by ... Vladimir Blagoderov bring together 18 papers by 81 authors to ... history collections. Centuries of exploration and discovery have documented ... biodiversity are, for the most part, distributed across varied ...
... discovered the structure and operating procedures of a ... alternative to antibiotics. In research published in ... Science USA, scientists from Monash University, The ... how the bacteriophage lysin, PlyC, kills bacteria that ...
Cached Biology News:Vanderbilt-led team to develop 'microbrain' to improve drug testing 2Vanderbilt-led team to develop 'microbrain' to improve drug testing 3Vanderbilt-led team to develop 'microbrain' to improve drug testing 4Vanderbilt-led team to develop 'microbrain' to improve drug testing 5Bringing natural history collections out of the dark 2New recruits in the fight against disease 2
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... Microplate Luminometer has been designed,for the ... for,all measurements of glow and flash ... the light remain nearly constant,over a ... as for very fast reactions,requiring at ...
... blotting. Get results sooner and save hours of ... Eliminates the need for a membrane transfer step ... are ready-to-use. No reagents to prepare or mix ... required. Guarantees a simple to perform, mistake-free detection ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
Biology Products: